Patents | Published:

Analyzing the protection scope limit for biosequence patent claims in China

Nature Biotechnology volume 36, pages 811813 (2018) | Download Citation

Though a patent's protection scope should be based on the content of the claims and written description, determining the protection scope of a biosequence patent has always been a controversial issue in practice.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Nat. Biotechnol. 10, 1001–1003 (2014).

  2. 2.

    China Patent Law, Article 26.4.

  3. 3.

    Administrative Retrial Judgment No. 86 by China's Supreme People's Court (2016).

  4. 4.

    China Patent No. 98813338.5, Thermostable glucoamylase (2006).

  5. 5.

    China's Guidelines for Patent Examination, Part Two, Chapter 10, 9.3.1.1 (2010).

Download references

Author information

Affiliations

  1. Wei Li is at the Law School of Zhejiang University of Finance and Economics, Hangzhou, China.

    • Wei Li

Authors

  1. Search for Wei Li in:

Corresponding author

Correspondence to Wei Li.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.4234

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing